Literature DB >> 21643939

Clinical usefulness of diffusion-weighted MR imaging for detection of pancreatic cancer: comparison with enhanced multidetector-row CT.

Kazuki Takakura1, Kazuki Sumiyama, Koji Munakata, Hirokazu Ashida, Seiji Arihiro, Hiroshi Kakutani, Hisao Tajiri.   

Abstract

PURPOSE: The aim of this study was to compare diffusion-weighted magnetic resonance imaging (DWI) and multidetector-row computed tomography (MDCT) for detection of primary pancreatic cancer by reviewing images of patients at high risk for pancreatic cancer with main pancreatic duct (MPD) dilatation shown by magnetic resonance cholangiopancreatography (MRCP).
METHODS: From October 2007 to September 2009, 83 patients who had undergone both DWI and MDCT with MPD dilatation were identified and were reviewed by four readers (2 radiologists and 2 gastroenterology fellows). Diagnostic performance in pancreatic cancer detection was evaluated with 95% confidence intervals. Statistically significant differences in the detection of pancreatic cancer between DWI and MDCT were compared by receiver operating characteristics and the confidence of the diagnosis by the paired t test.
RESULTS: Thirty-two of 83 patients were diagnosed with primary pancreatic cancer by histological evaluation of 15 surgical and 2 endoscopic ultrasound-guided fine needle aspiration samples, and by the clinical course for 15 lesions. Overall average accuracies of pancreatic cancer detection by the four readers were 84% with DWI and 86% with MDCT.
CONCLUSION: Performance of DWI and MDCT was equivocal for detection of pancreatic cancer in a high-risk population with MPD dilatation. The combination of MRCP and DWI for detection of pancreatic cancer allowed identification of a high-risk population and tumor detection with a single imaging modality with no need for contrast medium.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643939     DOI: 10.1007/s00261-011-9728-7

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  12 in total

Review 1.  Diffusion-weighted imaging of pancreatic cancer.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Flavia Dal Corso; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Radiol       Date:  2015-10-28

2.  Imaging of pancreatic cancer: An overview.

Authors:  Pavan Tummala; Omer Junaidi; Banke Agarwal
Journal:  J Gastrointest Oncol       Date:  2011-09

3.  Comparison of diffusion-weighted MRI acquisition techniques for normal pancreas at 3.0 Tesla.

Authors:  Xiu-Zhong Yao; Tiantao Kuang; Li Wu; Hao Feng; Hao Liu; Wei-Zhong Cheng; Sheng-Xiang Rao; He Wang; Meng-Su Zeng
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

Review 4.  CT and MRI of pancreatic tumors: an update in the era of radiomics.

Authors:  Marion Bartoli; Maxime Barat; Anthony Dohan; Sébastien Gaujoux; Romain Coriat; Christine Hoeffel; Christophe Cassinotto; Guillaume Chassagnon; Philippe Soyer
Journal:  Jpn J Radiol       Date:  2020-10-21       Impact factor: 2.374

5.  Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.

Authors:  Florencia McAllister; Maria F Montiel; Guneesh S Uberoi; Angad S Uberoi; Anirban Maitra; Manoop S Bhutani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

6.  Diffusion-weighted MR imaging of the pancreas: optimizing b-value for visualization of pancreatic adenocarcinoma.

Authors:  Yoshihiko Fukukura; Toshikazu Shindo; Hiroto Hakamada; Koji Takumi; Tomokazu Umanodan; Masanori Nakajo; Kiyoshisa Kamimura; Aya Umanodan; Junnichi Ideue; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2016-01-06       Impact factor: 5.315

7.  Controversies in ERCP: Indications and preparation.

Authors:  Christoph F Dietrich; Noor L Bekkali; Sean Burmeister; Yi Dong; Simon M Everett; Michael Hocke; Andre Ignee; Wei On; Srisha Hebbar; Kofi Oppong; Siyu Sun; Christian Jenssen; Barbara Braden
Journal:  Endosc Ultrasound       Date:  2022 May-Jun       Impact factor: 5.275

8.  Comparison of Multidetector CT and Gadobutrol-Enhanced MR Imaging for Evaluation of Small, Solid Pancreatic Lesions.

Authors:  Tae Won Choi; Jeong Min Lee; Jung Hoon Kim; Mi Hye Yu; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2016-06-27       Impact factor: 3.500

9.  Surgeons' knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study.

Authors:  Bing-Qi Li; Li Wang; Jian Li; Li Zhou; Tai-Ping Zhang; Jun-Chao Guo; Yu-Pei Zhao
Journal:  BMC Health Serv Res       Date:  2017-06-09       Impact factor: 2.655

10.  Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging.

Authors:  Ting-Ting Zhang; Li Wang; Huan-Huan Liu; Cai-Yuan Zhang; Xiao-Ming Li; Jian-Ping Lu; Deng-Bin Wang
Journal:  Oncotarget       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.